Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain
- PMID: 25644531
- PMCID: PMC4514173
- DOI: 10.1080/21645515.2015.1009339
Decline in rotavirus hospitalizations following the first three years of vaccination in Castile-La Mancha, Spain
Erratum in
-
Erratum.Hum Vaccin Immunother. 2015;11(12):2931-2. doi: 10.1080/21645515.2015.1122445. Hum Vaccin Immunother. 2015. PMID: 26697976 Free PMC article. No abstract available.
Abstract
Rotavirus is a major burden on the Spanish Healthcare System. Rotarix(®) and RotaTeq(®) were simultaneously commercialized in Spain by February, 2007. The objective is to analyze the incidence and seasonality of rotavirus hospitalizations (RH) in Castile-La Mancha (CLM), following the first 3 y of commercialization. A cross-sectional study of the hospital discharge registry's Minimum Basic Data Set (MBDS) in CLM between 2003 and 2009 was performed. We used the Poisson regression model to quantify the percentage of change in the rotavirus incidence rate (IR) for 2007-09 vs. 2003-05, adjusting for age, sex, and province. To analyze changes between epidemic seasons the chi-square test was used. The median IR in 2003-09 was 224.71 per 10(5) [interquartile range (IQR): 185.24-274.70], which represents 60% of hospital admissions due to infectious acute gastroenteritis. The median rate in 2007-09 decreased [incidence rate ratio (IRR): 0.86, 95% CI: 0.78-0.96], significantly in Toledo (IRR: 0.54, 95% CI: 0.39-0.75). An incipient decline at the beginning of the last cold season was observed, preceded by a significant decrease of 68% in the autumn season of 2009. Despite its limited coverage, the rotavirus vaccine may have contributed to decrease RH in CLM.
Keywords: AGE, Acute Gastroenteritis; ARGE, Acute Rotavirus Gastroenteritis; CLM, Castile-La Mancha; Children; IQR, Interquartile Range; IR, Incidence Rate; IRR, Incidence Rate Ratio; MBDS; MBDS, Minimum Basic Data Set; RH, rotavirus hospitalizations; Spain; hospitalizations; rotavirus; vaccines.
Figures





Similar articles
-
Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.BMC Infect Dis. 2017 Apr 11;17(1):267. doi: 10.1186/s12879-017-2380-2. BMC Infect Dis. 2017. PMID: 28399824 Free PMC article.
-
Acute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: a hospital-based surveillance study in Galicia, Spain.Hum Vaccin Immunother. 2012 Jul;8(7):946-52. doi: 10.4161/hv.20178. Epub 2012 Jun 8. Hum Vaccin Immunother. 2012. PMID: 22484280
-
Impact of non-routine rotavirus vaccination on hospitalizations for diarrhoea and rotavirus infections in Spain.Vaccine. 2013 Oct 9;31(43):5000-4. doi: 10.1016/j.vaccine.2013.05.109. Epub 2013 Jul 30. Vaccine. 2013. PMID: 23911782
-
[What have we learnt about rotavirus in Spain in the last 10 years?].An Pediatr (Engl Ed). 2019 Sep;91(3):166-179. doi: 10.1016/j.anpedi.2019.01.024. Epub 2019 Apr 7. An Pediatr (Engl Ed). 2019. PMID: 30971385 Spanish.
-
Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.Expert Rev Vaccines. 2014 Jan;13(1):43-57. doi: 10.1586/14760584.2014.861746. Epub 2013 Dec 4. Expert Rev Vaccines. 2014. PMID: 24308577 Review.
Cited by
-
Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain.BMC Infect Dis. 2017 Apr 11;17(1):267. doi: 10.1186/s12879-017-2380-2. BMC Infect Dis. 2017. PMID: 28399824 Free PMC article.
-
A multifactorial regression analysis of the features of community-acquired rotavirus requiring hospitalization in Spain as represented in the Minimum Basic Data Set.Epidemiol Infect. 2016 Sep;144(12):2509-16. doi: 10.1017/S0950268816000881. Epub 2016 May 6. Epidemiol Infect. 2016. PMID: 27150980 Free PMC article.
-
Spatio-temporal impact of self-financed rotavirus vaccination on rotavirus and acute gastroenteritis hospitalisations in the Valencia region, Spain.BMC Infect Dis. 2020 Sep 7;20(1):656. doi: 10.1186/s12879-020-05373-0. BMC Infect Dis. 2020. PMID: 32894071 Free PMC article.
-
Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018.BMC Infect Dis. 2021 Nov 6;21(1):1138. doi: 10.1186/s12879-021-06841-x. BMC Infect Dis. 2021. PMID: 34742235 Free PMC article.
-
Impact of self-financed rotavirus vaccines on hospital stays and costs in Spain after a 3-year introductory period.Epidemiol Infect. 2017 Jul;145(9):1773-1785. doi: 10.1017/S0950268817000620. Epub 2017 Apr 3. Epidemiol Infect. 2017. PMID: 28367780 Free PMC article.
References
-
- Pan American Health Organization/World Health Organization Epidemiological Surveillance of Diarrheal Diseases Due to Rotavirus - Field Guide. Scientific and Technical Publication No. 623; PAHO: Washington DC; 2010. [Internet]. [Accessed 23 oct 2013]. Available at: http://new.paho.org/hq/dmdocuments/2010/FieldGuide_Rotavirus_1stEd_e.pdf
-
- Hernández Pezzi G, Varela Martínez MC. Vigilancia epidemiológica de las gastroenteritis agudas víricas. Laia Alemany Vilches L, Moraga Llop F, García Jiménez S. En: Bellido Blasco JB, coordinador. 6 monografía de la Sociedad Española de Epidemiología. EMISA; 2007.
-
- Rivero MJ, Román E, García MI, Zafra M, Gil Á, González-Escalada A. Epidemiología de la gastroenteritis por rotavirus adquirida en la comunidad en el área de Fuenlabrada (Madrid). Enf Inf Microbiol Clin 2011; 29(6):432-4; http://dx.doi.org/10.1016/j.eimc.2011.03.007 - DOI - PubMed
-
- Ogilvie I, Khoury H, Goetghebeur MM, El Khoury AC, Giaquinto C. Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infect Dis 2012; 12:62; PMID:22429601; http://dx.doi.org/10.1186/1471-2334-12-62 - DOI - PMC - PubMed
-
- Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M, REVEAL Study Group . Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis 2007; 195 Suppl 1:S36-S44; PMID:17539193; http://dx.doi.org/10.1086/516716 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical